Literature DB >> 8931477

Role of nitric oxide in methamphetamine neurotoxicity: protection by 7-nitroindazole, an inhibitor of neuronal nitric oxide synthase.

D A Di Monte1, J E Royland, M W Jakowec, J W Langston.   

Abstract

The role of nitric oxide (NO.) in the neurotoxic effects of methamphetamine (METH) was evaluated using 7-nitroindazole (7-NI), a potent inhibitor of neuronal nitric oxide synthase. Treatment of mice with 7-NI (50 mg/kg) almost completely counteracted the loss of dopamine, 3,4-dihydroxyphenylacetic acid, and tyrosine hydroxylase immunoreactivity observed 5 days after four injections of 10 or 7.5 mg/kg METH. With the higher dose of METH, this protection at 5 days occurred despite the fact that combined administration of METH and 7-NI significantly increased lethality and exacerbated METH-induced dopamine release (as indicated by a greater dopamine depletion at 90 min and 1 day). Combined treatment with 4 x 10 mg/kg METH and 7-NI also slightly increased the body temperature of mice as compared with METH alone. Thus, the neuroprotective effects of 7-NI are independent from lethality, are not likely to be related to a reduction of METH-induced dopamine release, and are not due to a decrease in body temperature. These results indicate that NO. formation is an important step leading to METH neurotoxicity, and suggest that the cytotoxic properties of NO. may be directly involved in dopaminergic terminal damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8931477     DOI: 10.1046/j.1471-4159.1996.67062443.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

Review 1.  Mechanisms of methamphetamine-induced dopaminergic neurotoxicity.

Authors:  Evan L Riddle; Annette E Fleckenstein; Glen R Hanson
Journal:  AAPS J       Date:  2006       Impact factor: 4.009

2.  Molecular mechanism of the inactivation of tryptophan hydroxylase by nitric oxide: attack on critical sulfhydryls that spare the enzyme iron center.

Authors:  D M Kuhn; R Arthur
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

Review 3.  The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention.

Authors:  J A Molina; F J Jiménez-Jiménez; M Ortí-Pareja; J A Navarro
Journal:  Drugs Aging       Date:  1998-04       Impact factor: 3.923

4.  Peroxynitrite inactivation of tyrosine hydroxylase: mediation by sulfhydryl oxidation, not tyrosine nitration.

Authors:  D M Kuhn; C W Aretha; T J Geddes
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

5.  A study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brain.

Authors:  M I Colado; J Camarero; A O Mechan; V Sanchez; B Esteban; J M Elliott; A R Green
Journal:  Br J Pharmacol       Date:  2001-12       Impact factor: 8.739

6.  Expression and activity of nitric oxide synthase isoforms in methamphetamine-induced striatal dopamine toxicity.

Authors:  Danielle M Friend; Jong H Son; Kristen A Keefe; Ashley N Fricks-Gleason
Journal:  J Pharmacol Exp Ther       Date:  2012-12-10       Impact factor: 4.030

7.  Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis.

Authors:  Kristin E Larsen; Edward A Fon; Teresa G Hastings; Robert H Edwards; David Sulzer
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

8.  Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine.

Authors:  M J LaVoie; T G Hastings
Journal:  J Neurosci       Date:  1999-02-15       Impact factor: 6.167

Review 9.  Interactions of HIV and methamphetamine: cellular and molecular mechanisms of toxicity potentiation.

Authors:  J L Cadet; I N Krasnova
Journal:  Neurotox Res       Date:  2007-10       Impact factor: 3.911

10.  Modulation of methamphetamine-induced nitric oxide production by neuropeptide Y in the murine striatum.

Authors:  Haley L Yarosh; Jesus A Angulo
Journal:  Brain Res       Date:  2012-09-13       Impact factor: 3.252

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.